|
1
|
Zhao P, Dai M, Chen W and Li N: Cancer
trends in China. Jpn J Clin Oncol. 40:281–285. 2010.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ni J and Hua HQ: Progress in the treatment
of primary hepatocellular carcinoma by sorafenib combined with
traditional Chinese medicine. Mil Med J Southeast China.
17:175–177. 2015.
|
|
3
|
Han TS, Ban HS, Hur K and Cho HS: The
epigenetic regulation of HCC metastasis. Int J Mol Sci.
19(3978)2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Li Y, Tang ZY, Ye SL, Liu YK, Chen J, Xue
Q, Chen J, Gao DM and Bao WH: Establishment of cell clones with
different metastatic potential from the metastatic hepatocellular
carcinoma cell line MHCC97. World J Gastroenterol. 7:630–636.
2001.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Li Y, Tang Y, Ye L, Liu B, Liu K, Chen J
and Xue Q: Establishment of a hepatocellular carcinoma cell line
with unique metastatic characteristics through in vivo selection
and screening for metastasis-related genes through cDNA microarray.
J Cancer Res Clin Oncol. 129:43–51. 2003.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Li GC, Ye QH, Dong QZ, Ren N, Jia HL and
Qin LX: TGF beta1 and related-Smads contribute to pulmonary
metastasis of hepatocellular carcinoma in mice model. J Exp Clin
Cancer Res. 31(93)2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Batlle E and Clevers H: Cancer stem cells
revisited. Nat Med. 23:1124–1134. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Liu WH, Song FQ, Ren LN, Guo WQ, Wang T,
Feng YX, Tang LJ and Li K: The multiple functional roles of
mesenchymal stem cells in participating in treating liver diseases.
J Cell Mol Med. 19:511–520. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Vakhshiteh F, Atyabi F and Ostad SN:
Mesenchymal stem cell exosomes: A two-edged sword in cancer
therapy. Int J Nanomedicine. 14:2847–2859. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Tsuchiya A, Takeuchi S, Watanabe T,
Yoshida T, Nojiri S, Ogawa M and Terai S: Mesenchymal stem cell
therapies for liver cirrhosis: MSCs as ‘conducting cells’ for
improvement of liver fibrosis and regeneration. Inflamm Regen.
39(18)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Guo XZ, Liu X, Wang D, Zhao JJ, Li YH,
Shao XD and Ren LN: The effect of autologous bone marrow stem cell
transplantation on liver cirrhosis with different causes. Chin J
Digestion. 31:53–54. 2011.
|
|
12
|
Vainshtein JM, Kabarriti R, Mehta KJ,
Roy-Chowdhury J and Guha C: Bone marrow-derived stromal cell
therapy in cirrhosis: Clinical evidence, cellular mechanisms, and
implications for the treatment of hepatocellular carcinoma. Int J
Radiat Oncol Biol Phys. 89:786–803. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yin Z, Jiang K, Li R, Dong C and Wang L
and Wang L: Multipotent mesenchymal stromal cells play critical
roles in hepatocellular carcinoma initiation, progression and
therapy. Mol Cancer. 17(178)2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Liu Y, Ren H, Zhou Y, Shang L, Zhang Y,
Yang F and Shi X: The hypoxia conditioned mesenchymal stem cells
promote hepatocellular carcinoma progression through YAP mediated
lipogenesis reprogramming. J Exp Clin Cancer Res.
38(228)2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Li TR, Cai LJ, Zhao SH, Wei ZM, Huo TL, Lu
GM and Song B: Effect of OPN transfected BMSCs on MHCC97-H. Chin J
Gastroenterol Hepatol. 24:1057–1061. 2015.
|
|
16
|
Li GC, Ye QH, Xue YH, Sun HJ, Zhou HJ, Ren
N, Jia HL, Shi J, Wu JC, Dai C, et al: Human mesenchymal stem cells
inhibit metastasis of a hepatocellular carcinoma model using the
MHCC97-H cell line. Cancer Sci. 101:2546–2553. 2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Li TR, Du XK, Song B, Ye YK, Wei ZM and
Huo TL: Experimental study of TGFβ 1 transfected hMSC intervene
MHCC97-H. Chin J Gastroenterol Hepatol. 22:615–619. 2013.
|
|
18
|
Li GC, Zhang HW, Zhao QC, Sun LI, Yang JJ,
Hong L, Feng F and Cai L: Mesenchymal stem cells promote tumor
angiogenesis via the action of transforming growth factor β 1.
Oncol Lett. 11:1089–1094. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhang R, Pan X, Huang Z, Weber GF and
Zhang G: Osteopontin enhances the expression and activity of MMP-2
via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines.
PLoS One. 6(e23831)2011.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Weber CE, Kothari AN, Wai PY, Li NY,
Driver J, Zapf MA, Franzen CA, Gupta GN, Osipo C, Zlobin A, et al:
Osteopontin mediates an MZF1-TGF-β 1-dependent transformation of
mesenchymal stem cells into cancer-associated fibroblasts in breast
cancer. Oncogene. 34:4821–4833. 2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
General Administration of Quality
Supervision, Inspection and Quarantine of the People’s Republic of
China, and Standardization Administration of the People’s Republic
of China: Laboratory animals-Nutrients for formula feeds (GB
14924.3-2010) issued by National Standards of People’s Republic of
China, December 23, 2010. http://www.gb688.cn/bzgk/gb.
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Marshall J: Transwell® invasion
assays. Methods Mol Biol. 769:97–110. 2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kang Y: Imaging TGFβ signaling in mouse
models of cancer metastasis. Methods Mol Biol. 1344:219–232.
2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Icer MA and Gezmen-Karadag M: The multiple
functions and mechanisms of osteopontin. Clin Biochem. 59:17–24.
2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ye QH, Qin LX, Forgues M, He P, Kim JW,
Peng AC, Simon R, Li Y, Robles AI, Chen Y, et al: Predicting
hepatitis B virus-positive metastatic hepatocellular carcinomas
using gene expression profiling and supervised machine learning.
Nat Med. 9:416–423. 2003.PubMed/NCBI View
Article : Google Scholar
|
|
27
|
Huang H, Zhang XF, Zhou HJ, Xue YH, Dong
QZ, Ye QH and Qin LX: Expression and prognostic significance of
osteopontin and caspase-3 in hepatocellular carcinoma patients
after curative resection. Cancer Sci. 101:1314–1319.
2010.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Budhu A and Wang XW: The role of cytokines
in hepatocellular carcinoma. J Leukoc Biol. 80:1197–1213.
2006.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Tang J, Gifford CC, Samarakoon R and
Higgins PJ: Deregulation of negative controls on TGF-β 1 signaling
in tumor progression. Cancers (Basel). 10(159)2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Hayashida T, Jones JC, Lee CK and Schnaper
HW: Loss of beta1-integrin enhances TGF-beta1-induced collagen
expression in epithelial cells via increased alphavbeta3-integrin
and Rac1 activity. J Biol Chem. 285:30741–30751. 2010.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Li MO, Wan YY, Sanjabi S, Robertson AK and
Flavell RA: Transforming growth factor-beta regulation of immune
responses. Annu Rev Immunol. 24:99–146. 2006.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Prasad P, Tiwari AK, Kumar KM, Ammini AC,
Gupta A, Gupta R and Thelma BK: Association of TGFbeta1, TNFalpha,
CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal
insufficiency among Asian Indians. BMC Med Genet.
8(20)2007.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Li D, Liu Q, Qi L, Dai X, Liu H and Wang
Y: Low levels of TGF-β 1 enhance human umbilical cord-derived
mesenchymal stem cell fibronectin production and extend survival
time in a rat model of lipopolysaccharide-induced acute lung
injury. Mol Med Rep. 14:1681–1692. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
de Araújo Farias V, Carrillo-Gálveza AB,
Martína F and Andersona P: TGF-β and mesenchymal stromal cells in
regenerative medicine, autoimmunity and cancer. Cytokine Growth
Factor Rev. 43:25–37. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Molfino A, Amabile MI and Muscaritoli M:
Nutrition support for treating cancer-associated weight loss: An
update. Curr Opin Support Palliat Care. 12:434–438. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhu Y, Gao XM, Yang J, Xu D, Zhang Y, Lu
M, Zhang Z, Sheng YY, Li JH, Yu XX, et al: C-C chemokine receptor
type 1 mediates osteopontin-promoted metastasis in hepatocellular
carcinoma. Cancer Sci. 109:710–723. 2018.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Neuzillet C, de Gramont A,
Tijeras-Raballand A, de Mestier L, Cros J, Faivre S and Raymond E:
Perspectives of TGF-β inhibition in pancreatic and hepatocellular
carcinomas. Oncotarget. 5:78–94. 2014.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Zhou JP and Zhou WP: Expression of VEGF,
integrin αV and MVD in viable residual tumor tissues from large
hepatocellular carcinoma after TACE. Mil Med J Southeast China.
12:206–208. 2010.
|
|
39
|
Li TR, Yu MH, Huang XB, Yang ZJ, Lu GM and
Li YJ: Magnetic resonance Gd-RGD imaging study of hepatocellular
carcinoma with high and low metastatic potential before and after
human bone marrow-derived mesenchymal stem cell intervention. Chin
Med J (Engl). 130:2591–2600. 2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Hayashida T, Wu MH, Pierce A, Poncelet AC,
Varga J and Schnaper HW: MAP-kinase activity necessary for
TGFbeta1-stimulated mesangial cell type I collagen expression
requires adhesion-dependent phosphorylation of FAK tyrosine 397. J
Cell Sci. 120:4230–4240. 2007.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Li Y, Liu G, Li X, Dong H, Xiao W and Lu
S: Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma
progression through regulation of miR-140-5p-TGFBR1 pathway.
Biochem Biophys Res Commun. 503:2826–2832. 2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Wen X, Yao M, Lu Y, Chen J, Zhou J, Chen
X, Zhang Y, Lu W, Qian X, Zhao J, et al: Integration of prealbumin
into child-pugh classification improves prognosis predicting
accuracy in HCC patients considering curative surgery. J Clin
Transl Hepatol. 6:377–384. 2018.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Deng Q, Zhang Z, Feng X, Li T, Liu N, Lai
J, Shuai L, Xiong Q, Fu C, Zou H, et al: TRAIL-secreting
mesenchymal stem cells promote apoptosis in heat-shock-treated
liver cancer cells and inhibit tumor growth in nude mice. Gene
Ther. 21:317–327. 2014.PubMed/NCBI View Article : Google Scholar
|
